Home > Category > Signaling Pathways > GPCR & G Protein > Prostaglandin Receptor > NS-304 (Selexipag; ACT-293987)

NS-304 (Selexipag; ACT-293987)

ChemLeader 98+%

Catalog No：CL2526 CAS No.：475086-01-2 MDLNo： Formula：C26H32N4O4S MW：496.62

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$100.00	Visible after login	- +
5 mg	3-5days	$125.00	Visible after login	- +
10 mg	3-5days	$200.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	NS-304 (Selexipag; ACT-293987)
CAS	475086-01-2
Formula	C26H32N4O4S
MW	496.62
Appearance	White to yellow powder

Product details

Selexipag, also known as ACT-293987 and NS-304, is a a first-in-class orally available selective non-prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT-333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2526

NS-304 (Selexipag; ACT-293987)

Vasicine hydrochloride

7174-27-8 98+%